Watson's Generic Fentora Receives FDA Approval

Watson Pharmaceuticals, Inc. WPI today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration for Fentanyl Buccal tablets, USP, in the 0.1, 0.2, 0.4, 0.6 and 0.8 mg strengths, the generic equivalent to Cephalon's Fentora ® tablets.